p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
About this item
Full title
Author / Creator
Giordano, Federica , Vaira, Valentina , Cortinovis, Diego , Bonomo, Sara , Goedmakers, Joyce , Brena, Federica , Cialdella, Annamaria , Ianzano, Leonarda , Forno, Irene , Cerrito, Maria Grazia , Giovannoni, Roberto , Ferri, Gian Luca , Tasciotti, Ennio , Vicent, Silve , Damarco, Francesco , Bosari, Silvano , Lavitrano, Marialuisa and Grassilli, Emanuela
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Lung cancer is still the main cause of cancer death worldwide despite the availability of targeted therapies and immune-checkpoint inhibitors combined with chemotherapy. Cancer cell heterogeneity and primary or acquired resistance mechanisms cause the elusive behaviour of this cancer and new biomarkers and active drugs are urgently needed to overco...
Alternative Titles
Full title
p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma
Authors, Artists and Contributors
Author / Creator
Vaira, Valentina
Cortinovis, Diego
Bonomo, Sara
Goedmakers, Joyce
Brena, Federica
Cialdella, Annamaria
Ianzano, Leonarda
Forno, Irene
Cerrito, Maria Grazia
Giovannoni, Roberto
Ferri, Gian Luca
Tasciotti, Ennio
Vicent, Silve
Damarco, Francesco
Bosari, Silvano
Lavitrano, Marialuisa
Grassilli, Emanuela
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b782b3e4740b439d83d43665504dfb5f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b782b3e4740b439d83d43665504dfb5f
Other Identifiers
ISSN
1756-9966,0392-9078
E-ISSN
1756-9966
DOI
10.1186/s13046-019-1199-7
